231 related articles for article (PubMed ID: 29098501)
1. Rationale and Design of Low-dose Administration of Carperitide for Acute Heart Failure (LASCAR-AHF).
Nagai T; Honda Y; Nakano H; Honda S; Iwakami N; Mizuno A; Komiyama N; Yamane T; Furukawa Y; Miyagi T; Nishihara S; Tanaka N; Adachi T; Hamasaki T; Asaumi Y; Tahara Y; Aiba T; Sugano Y; Kanzaki H; Noguchi T; Kusano K; Yasuda S; Ogawa H; Anzai T
Cardiovasc Drugs Ther; 2017 Dec; 31(5-6):551-557. PubMed ID: 29098501
[TBL] [Abstract][Full Text] [Related]
2. Effect of intravenous carperitide versus nitrates as first-line vasodilators on in-hospital outcomes in hospitalized patients with acute heart failure: Insight from a nationwide claim-based database.
Nagai T; Iwakami N; Nakai M; Nishimura K; Sumita Y; Mizuno A; Tsutsui H; Ogawa H; Anzai T;
Int J Cardiol; 2019 Apr; 280():104-109. PubMed ID: 30674432
[TBL] [Abstract][Full Text] [Related]
3. Carperitide Is Associated With Increased In-Hospital Mortality in Acute Heart Failure: A Propensity Score-Matched Analysis.
Matsue Y; Kagiyama N; Yoshida K; Kume T; Okura H; Suzuki M; Matsumura A; Yoshida K; Hashimoto Y
J Card Fail; 2015 Nov; 21(11):859-64. PubMed ID: 25999241
[TBL] [Abstract][Full Text] [Related]
4. Effects of Carperitide on Degree of Pulmonary Congestion in Treatment of Acute Heart Failure.
Kawase Y; Hata R; Tada T; Katoh H; Kadota K
Circ J; 2018 Jul; 82(8):2079-2088. PubMed ID: 29794402
[TBL] [Abstract][Full Text] [Related]
5. Serelaxin in addition to standard therapy in acute heart failure: rationale and design of the RELAX-AHF-2 study.
Teerlink JR; Voors AA; Ponikowski P; Pang PS; Greenberg BH; Filippatos G; Felker GM; Davison BA; Cotter G; Gimpelewicz C; Boer-Martins L; Wernsing M; Hua TA; Severin T; Metra M
Eur J Heart Fail; 2017 Jun; 19(6):800-809. PubMed ID: 28452195
[TBL] [Abstract][Full Text] [Related]
6. Effect of carperitide on the 1 year prognosis of patients with acute decompensated heart failure.
Nogi K; Ueda T; Matsue Y; Nogi M; Ishihara S; Nakada Y; Kawakami R; Kagiyama N; Kitai T; Oishi S; Akiyama E; Suzuki S; Yamamoto M; Kida K; Okumura T; Saito Y
ESC Heart Fail; 2022 Apr; 9(2):1061-1070. PubMed ID: 35118813
[TBL] [Abstract][Full Text] [Related]
7. Comparison of salt with low-dose furosemide and carperitide for treating acute decompensated heart failure: a single-center retrospective cohort study.
Okuhara Y; Hirotani S; Ando T; Nishimura K; Orihara Y; Komamura K; Naito Y; Mano T; Masuyama T
Heart Vessels; 2017 Apr; 32(4):419-427. PubMed ID: 27469321
[TBL] [Abstract][Full Text] [Related]
8. Evaluating the Efficacy, Safety, and Tolerability of Serelaxin When Added to Standard Therapy in Asian Patients With Acute Heart Failure: Design and Rationale of RELAX-AHF-ASIA Trial.
Sato N; Lam CS; Teerlink JR; Greenberg BH; Tsutsui H; Oh BH; Zhang J; Lefkowitz M; Hua TA; Holbro T; Marshood M; Wang XL; Ge J
J Card Fail; 2017 Jan; 23(1):63-71. PubMed ID: 27825893
[TBL] [Abstract][Full Text] [Related]
9. Predictors of responders for low-dose carperitide monotherapy in patients with acute heart failure.
Kamiya M; Sato N; Matsuda J; Nozaki A; Akiya M; Sato T; Okazaki H; Takahashi Y; Shimizu W
Heart Vessels; 2020 Jan; 35(1):59-68. PubMed ID: 31227874
[TBL] [Abstract][Full Text] [Related]
10. The impact of carperitide usage on the cost of hospitalization and outcome in patients with acute heart failure: High value care vs. low value care campaign in Japan.
Mizuno A; Iguchi H; Sawada Y; Hurley M; Nomura H; Hayashi K; Tokuda Y; Watanabe S; Yoshikawa A
Int J Cardiol; 2017 Aug; 241():243-248. PubMed ID: 28476514
[TBL] [Abstract][Full Text] [Related]
11. Vasodilators in acute heart failure - evidence based on new studies.
Travessa AM; Menezes Falcão L
Eur J Intern Med; 2018 May; 51():1-10. PubMed ID: 29482882
[TBL] [Abstract][Full Text] [Related]
12. Effect of a Strategy of Comprehensive Vasodilation vs Usual Care on Mortality and Heart Failure Rehospitalization Among Patients With Acute Heart Failure: The GALACTIC Randomized Clinical Trial.
Kozhuharov N; Goudev A; Flores D; Maeder MT; Walter J; Shrestha S; Gualandro DM; de Oliveira Junior MT; Sabti Z; Müller B; Noveanu M; Socrates T; Ziller R; Bayés-Genís A; Sionis A; Simon P; Michou E; Gujer S; Gori T; Wenzel P; Pfister O; Conen D; Kapos I; Kobza R; Rickli H; Breidthardt T; Münzel T; Erne P; Mueller C; ; Mueller C; Erne P; Müller B; Rickli H; Maeder M; Tavares de Oliveira M; Münzel T; Bayés-Genís A; Sionis A; Goudev A; Dimov B; Hartwiger S; Arenja N; Glatz B; Herr N; Isenrich R; Mosimann T; Twerenbold R; Boeddinghaus J; Nestelberger T; Puelacher C; Freese M; Vögele J; Meissner K; Martin J; Strebel I; Wussler D; Schumacher C; Osswald S; Vogt F; Hilti J; Barata S; Schneider D; Schwarz J; Fitze B; Hartwiger S; Arenja N; Glatz B; Herr N; Isenrich R; Mosimann T; Twerenbold R; Boeddinghaus J; Nestelberger T; Puelacher C; Freese M; Vögele J; Meissner K; Martin J; Strebel I; Wussler D; Schumacher C; Osswald S; Vogt F; Hilti J; Barata S; Schneider D; Schwarz J; Fitze B; Arenja N; Rentsch K; Bossa A; Jallad S; Soeiro A; Georgiev D; Jansen T; Gebel G; Bossard M; Christ M
JAMA; 2019 Dec; 322(23):2292-2302. PubMed ID: 31846016
[TBL] [Abstract][Full Text] [Related]
13. Effect of carperitide on in-hospital mortality of patients admitted for heart failure: propensity score analyses.
Ogiso M; Isogai T; Okabe Y; Ito K; Tsuji M; Tanaka H
Heart Vessels; 2017 Aug; 32(8):916-925. PubMed ID: 28220240
[TBL] [Abstract][Full Text] [Related]
14. Systolic blood pressure at admission as a predictor of the response to initial carperitide therapy in patients hospitalized for acute decompensated heart failure with left ventricular systolic dysfunction.
Kajimoto K; Sashida Y; Minami Y; Yumino D; Kawarai H; Kasanuki H
Cardiovasc Drugs Ther; 2009 Dec; 23(6):481-8. PubMed ID: 19937464
[TBL] [Abstract][Full Text] [Related]
15. Acute heart failure: lessons learned so far.
Howlett JG
Can J Cardiol; 2011; 27(3):284-95. PubMed ID: 21601768
[TBL] [Abstract][Full Text] [Related]
16. Rationale and design of the Acute Study of Clinical Effectiveness of Nesiritide in Decompensated Heart Failure Trial (ASCEND-HF).
Hernandez AF; O'Connor CM; Starling RC; Reist CJ; Armstrong PW; Dickstein K; Lorenz TJ; Gibler WB; Hasselblad V; Komajda M; Massie B; McMurray JJ; Nieminen M; Rouleau JL; Swedberg K; Califf RM
Am Heart J; 2009 Feb; 157(2):271-7. PubMed ID: 19185633
[TBL] [Abstract][Full Text] [Related]
17. Effects of carperitide on the long-term prognosis of patients with acute decompensated chronic heart failure: the PROTECT multicenter randomized controlled study.
Hata N; Seino Y; Tsutamoto T; Hiramitsu S; Kaneko N; Yoshikawa T; Yokoyama H; Tanaka K; Mizuno K; Nejima J; Kinoshita M
Circ J; 2008 Nov; 72(11):1787-93. PubMed ID: 18812677
[TBL] [Abstract][Full Text] [Related]
18. Design of the RELAXin in acute heart failure study.
Ponikowski P; Metra M; Teerlink JR; Unemori E; Felker GM; Voors AA; Filippatos G; Greenberg B; Teichman SL; Severin T; Mueller-Velten G; Cotter G; Davison BA
Am Heart J; 2012 Feb; 163(2):149-55.e1. PubMed ID: 22305830
[TBL] [Abstract][Full Text] [Related]
19. [Effects of carperitide (alpha-human atrial natriuretic peptide) on acute congestive heart failure in dogs].
Hidaka T; Aisaka K; Ohno T; Ishihara T
Nihon Yakurigaku Zasshi; 1993 Apr; 101(4):233-51. PubMed ID: 8514207
[TBL] [Abstract][Full Text] [Related]
20. Relief and Recurrence of Congestion During and After Hospitalization for Acute Heart Failure: Insights From Diuretic Optimization Strategy Evaluation in Acute Decompensated Heart Failure (DOSE-AHF) and Cardiorenal Rescue Study in Acute Decompensated Heart Failure (CARESS-HF).
Lala A; McNulty SE; Mentz RJ; Dunlay SM; Vader JM; AbouEzzeddine OF; DeVore AD; Khazanie P; Redfield MM; Goldsmith SR; Bart BA; Anstrom KJ; Felker GM; Hernandez AF; Stevenson LW
Circ Heart Fail; 2015 Jul; 8(4):741-8. PubMed ID: 26041600
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
